BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16304045)

  • 1. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1gamma) in osteoclastogenesis in vivo and in vitro.
    Yang M; Mailhot G; MacKay CA; Mason-Savas A; Aubin J; Odgren PR
    Blood; 2006 Mar; 107(6):2262-70. PubMed ID: 16304045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts.
    Lean JM; Murphy C; Fuller K; Chambers TJ
    J Cell Biochem; 2002; 87(4):386-93. PubMed ID: 12397598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival.
    Okamatsu Y; Kim D; Battaglino R; Sasaki H; Späte U; Stashenko P
    J Immunol; 2004 Aug; 173(3):2084-90. PubMed ID: 15265944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of colony-stimulating factor-1 (CSF-1) on the development of osteoclasts and their expression of tartrate-resistant acid phosphatase (TRAP) in toothless (tl-osteopetrotic) rats.
    Norgård M; Marks SC; Reinholt FP; Andersson G
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):117-32. PubMed ID: 14696961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis.
    Yang M; Mailhot G; Birnbaum MJ; MacKay CA; Mason-Savas A; Odgren PR
    J Biol Chem; 2006 Aug; 281(33):23598-605. PubMed ID: 16787916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function.
    Lean JM; Fuller K; Chambers TJ
    Blood; 2001 Nov; 98(9):2707-13. PubMed ID: 11675341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells.
    Yamada T; Yamazaki H; Yamane T; Yoshino M; Okuyama H; Tsuneto M; Kurino T; Hayashi S; Sakano S
    Blood; 2003 Mar; 101(6):2227-34. PubMed ID: 12411305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T
    J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone receptor and insulin-like growth factor-I immunoreactivity in osteoclast-like cells during tooth eruption in the toothless (osteopetrotic) rat following treatment with colony-stimulating factor-1.
    Symons AL; Weerakoon A; Marks SC
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):195-204. PubMed ID: 14696967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
    J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifurcation of osteoclasts and dendritic cells from common progenitors.
    Miyamoto T; Ohneda O; Arai F; Iwamoto K; Okada S; Takagi K; Anderson DM; Suda T
    Blood; 2001 Oct; 98(8):2544-54. PubMed ID: 11588053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT
    J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of colony stimulating factor-1 to toothless osteopetrotic rats normalizes osteoblast, but not osteoclast, gene expression.
    Wisner-Lynch LA; Shalhoub V; Marks SC
    Bone; 1995 Jun; 16(6):611-8. PubMed ID: 7669437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of colony-stimulating factor-1 on the number and ultrastructure of osteoclasts in toothless (tl) rats and osteopetrotic (op) mice.
    Marks SC; Iizuka T; MacKay CA; Mason-Savas A; Cielinski MJ
    Tissue Cell; 1997 Oct; 29(5):589-95. PubMed ID: 9364807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.